Literature DB >> 19357084

Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors.

Gábor Turu1, Péter Várnai, Pál Gyombolai, László Szidonya, László Offertaler, György Bagdy, George Kunos, László Hunyady.   

Abstract

Intracellular signaling systems of G protein-coupled receptors are well established, but their role in paracrine regulation of adjacent cells is generally considered as a tissue-specific mechanism. We have shown previously that AT(1) receptor (AT(1)R) stimulation leads to diacylglycerol lipase-mediated transactivation of co-expressed CB(1)Rs in Chinese hamster ovary cells. In the present study we detected a paracrine effect of the endocannabinoid release from Chinese hamster ovary, COS7, and HEK293 cells during the stimulation of AT(1) angiotensin receptors by determining CB(1) cannabinoid receptor activity with bioluminescence resonance energy transfer-based sensors of G protein activation expressed in separate cells. The angiotensin II-induced, paracrine activation of CB(1) receptors was visualized by detecting translocation of green fluorescent protein-tagged beta-arrestin2. Mass spectrometry analyses have demonstrated angiotensin II-induced stimulation of 2-arachidonoylglycerol production, whereas no increase of anandamide levels was observed. Stimulation of G(q/11)-coupled M(1), M(3), M(5) muscarinic, V(1) vasopressin, alpha(1a) adrenergic, B(2) bradykinin receptors, but not G(i/o)-coupled M(2) and M(4) muscarinic receptors, also led to paracrine transactivation of CB(1) receptors. These data suggest that, in addition to their retrograde neurotransmitter role, endocannabinoids have much broader paracrine mediator functions during activation of G(q/11)-coupled receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357084      PMCID: PMC2719328          DOI: 10.1074/jbc.M109.003681

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  A fluorescence resonance energy transfer-based sensor indicates that receptor access to a G protein is unrestricted in a living mammalian cell.

Authors:  Inaki Azpiazu; N Gautam
Journal:  J Biol Chem       Date:  2004-04-12       Impact factor: 5.157

2.  Toward an anandamide transporter.

Authors:  Raphael Mechoulam; Dale G Deutsch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-28       Impact factor: 11.205

Review 3.  Transmembrane signaling by G protein-coupled receptors.

Authors:  Louis M Luttrell
Journal:  Methods Mol Biol       Date:  2006

4.  Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes.

Authors:  Céline Galés; Joost J J Van Durm; Stéphane Schaak; Stéphanie Pontier; Yann Percherancier; Martin Audet; Hervé Paris; Michel Bouvier
Journal:  Nat Struct Mol Biol       Date:  2006-08-13       Impact factor: 15.369

Review 5.  Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.

Authors:  László Hunyady; Kevin J Catt
Journal:  Mol Endocrinol       Date:  2005-09-01

Review 6.  GPCR agonists and antagonists in the clinic.

Authors:  Joel D A Tyndall; Radhika Sandilya
Journal:  Med Chem       Date:  2005-07       Impact factor: 2.745

Review 7.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 8.  The 7 TM G-protein-coupled receptor target family.

Authors:  Edgar Jacoby; Rochdi Bouhelal; Marc Gerspacher; Klaus Seuwen
Journal:  ChemMedChem       Date:  2006-08       Impact factor: 3.466

Review 9.  Cardiovascular pharmacology of cannabinoids.

Authors:  P Pacher; S Bátkai; G Kunos
Journal:  Handb Exp Pharmacol       Date:  2005

Review 10.  Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.

Authors:  Takayuki Sugiura; Seishi Kishimoto; Saori Oka; Maiko Gokoh
Journal:  Prog Lipid Res       Date:  2006-04-19       Impact factor: 16.195

View more
  22 in total

Review 1.  Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action.

Authors:  Pál Gyombolai; Dorottya Pap; Gábor Turu; Kevin J Catt; György Bagdy; László Hunyady
Journal:  Mol Cell Endocrinol       Date:  2011-11-02       Impact factor: 4.102

Review 2.  Pharmacological characterization of GPR55, a putative cannabinoid receptor.

Authors:  Haleli Sharir; Mary E Abood
Journal:  Pharmacol Ther       Date:  2010-03-16       Impact factor: 12.310

Review 3.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

4.  Heterologous phosphorylation-induced formation of a stability lock permits regulation of inactive receptors by β-arrestins.

Authors:  András D Tóth; Susanne Prokop; Pál Gyombolai; Péter Várnai; András Balla; Vsevolod V Gurevich; László Hunyady; Gábor Turu
Journal:  J Biol Chem       Date:  2017-11-16       Impact factor: 5.157

Review 5.  Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists.

Authors:  E Kirilly; L Hunyady; G Bagdy
Journal:  J Neural Transm (Vienna)       Date:  2012-09-19       Impact factor: 3.575

6.  Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities.

Authors:  M A Cosenza-Nashat; A Bauman; M-L Zhao; S Morgello; H-S Suh; S C Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

7.  Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

Authors:  Tony Jourdan; Gergő Szanda; Avi Z Rosenberg; Joseph Tam; Brian James Earley; Grzegorz Godlewski; Resat Cinar; Ziyi Liu; Jie Liu; Cynthia Ju; Pál Pacher; George Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

Review 8.  Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism.

Authors:  Georges Vauquelin; Sophie Bostoen; Patrick Vanderheyden; Philip Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-14       Impact factor: 3.000

9.  Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors.

Authors:  Mária Szekeres; György L Nádasy; Gábor Turu; Eszter Soltész-Katona; Zsuzsanna E Tóth; András Balla; Kevin J Catt; László Hunyady
Journal:  J Biol Chem       Date:  2012-07-11       Impact factor: 5.157

Review 10.  The Endocannabinoid Signaling System in the CNS: A Primer.

Authors:  Cecilia J Hillard
Journal:  Int Rev Neurobiol       Date:  2015-11-06       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.